Ortho Evra Patch Makers Settling Cases ( DANVILLE Calif. April 21 /- Ortho...)

Ortho Evra Patch Makers Settling Cases

Date:4/21/2008

DANVILLE, Calif., April 21 /PRNewswire/ -- Ortho Evra is an adhesive, transdermal birth control patch. It is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. It is replaced once a week for three weeks, and no patch is worn during the fourth week. Ortho Evra was approved by the FDA in November 2001, and over 4 million women have used Ortho Evra since its approval. Ortho Evra continues to be marketed aggressively to both consumers and physicians.

Evidence shows that Ortho Evra is dangerous and should be recalled from the market. Studies found that women using the Ortho Evra birth control patch were twice as likely to develop blood clots compared with those using oral birth control pills.

As a result of these studies, The Food and Drug Administration updated Ortho Evra's warning language to reflect that women using the patch faced twice the risk of blood clots as women on the pill.

This is not the first time there have been changes made to the warnings about Ortho Evra's risks. The first warning about the increased risks of blood clots associated with Ortho Evra was issued on November 10, 2005. In that warning, Ortho-McNeil, one of the manufacturers of Ortho Evra, admitted for the first time that women who use the patch will be exposed to up to 60% more estrogen than those taking a birth control pill with 35 micrograms of estrogen. The patch is only intended to deliver 20 micrograms of estrogen.

It is alleged that Ortho-McNeil was aware of the increased medical risks associated with Ortho Evra before the drug was approved and that, once approved, the company failed to adequately warn patients about these risks. Evidence shows that the risk of blood clots, heart attack and stroke associated with Ortho Evra is significantly higher than with oral contraceptive pills.

The contraceptive patch continues to be aggressively marketed using Olympic athletes, sexy ads and fas
'/>"/>

SOURCE Alexander Hawes, LLP
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
2. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
3. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
4. ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
5. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
6. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
7. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
8. Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference
9. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
10. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
11. Progentix Orthobiology B.V. Closes Series A Financing Round

Post Your Comments:

(Date:5/23/2013)... -- Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that Jeffrey ... two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ) ... Annual Marcum LLP Microcap Conference on Thursday, May 30, ... City. The presentation is scheduled to begin at 4:30 ...

(Date:5/23/2013)... 23, 2013 Pusan National University Yangsan ... biotherapeutics and contract research company focused on research ... announced today a publication reporting the induction of ... oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex ... in the May 15 th , 2013 issue ...

(Date:5/23/2013)... May 23, 2013 African ... tracing for people of African descent, today announced ... offering. For people of all races, myDNAmix determines ... five distinct populations: Indigenous Americas (Native American), East ... Subcontinent. , Originally launched in late ...

(Date:5/23/2013)... 2013 Bed bugs compromised Penn ... already confirmed it. Meanwhile, My Cleaning Products offered complimentary samples ... fight the pests without using harmful chemical elements. , ... 2013, the affected building was actually a dormitory , ... said made on May 13 and bed bug presence was ...

Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2 Verenium To Present At Two Upcoming Conferences 3 Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2 Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3 AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2 AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3 Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2

[0] Verenium To Present At Two Upcoming Conferences [0] Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment [0] AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup [0] Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims

... Harriet L. Robinson, Ph.D., Chief Scientific Officer at ... in the development of HIV/AIDS vaccines, announced the results ... step closer to a vaccine that protects against multiple ... by Dr. Robinson during a presentation in Seattle at ...

... local product advancements and a strong 2012 research pipeline ... growth, Pioneer President Paul E. Schickler told ... "Global trends like an expanding middle class ... demand for food and require constant innovation, global science ...

... March 7, 2012 Palatin Technologies, Inc. (NYSE Amex: ... the 24th Annual ROTH OC Growth Stock Conference on Tuesday, ... will be held at the Ritz Carlton Laguna Niguel in ... and Chief Executive Officer of Palatin Technologies, will provide an ...

Cached Biology Technology:GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 2 GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 3 GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 4 DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 2 DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 3

GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)DuPont Leader Overviews 2012 Seed Research Pipeline with Investors Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference

(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...

(Date:5/22/2013)... changes in cellular DNA can endanger the whole organism, ... Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how ... double helix. , The DNA in our cells controls ... our bodies. The instructions for this are encoded in ... DNA, the bases adenine (A), cytosine (C), guanine (G) ...

(Date:5/22/2013)... biodiversity of pollinating insects and wild plants have slowed ... Researchers led by the University of Leeds and the ... of dramatic reductions in the diversity of species in ... 1980s. , But the picture brightened markedly after 1990, ... among bees, hoverflies and wild plants. , ...

Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2 Encouraging signs for bee biodiversity 2 Encouraging signs for bee biodiversity 3

[0] Meeting the 'grand challenge' of a sustainable water supply [0] DNA damage: The dark side of respiration [0] Encouraging signs for bee biodiversity

... issue of Sports Technology , published by ... the gap between able-bodied athletes and para-athletes, with ... first article, entitled "Biomechanics of double transtibial amputee ... al., compares the sprinting mechanics data of able-bodied ...

... patients with a particularly aggressive form of skin cancer ... from simply hearing that diagnosis, might amplify the progression ... that infers this also suggests that the use of ... of those tumors and therefore improve these patients, quality ...

... Entrust, Inc. (Nasdaq: ENTU ), a world leader in ... fiscal quarter and year ended December 31, 2008.Fourth-Quarter 2008, ... of $24.9 million, a decrease of 7% over Q4 2007; total ... million, an increase of 5%, adjusting for currency , ...

Sports technology for para-athletes: Closing the gap Stress may hasten the growth of melanoma tumors Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008

Mycoplasma and virus tested...

... MagicMark and MagicMark XP Western Protein ... and convenient protein molecular weight estimation ... protein contains an IgG binding site, ... antibody-conjugate reagents used to detect your ...

... Immunogen: Synthetic peptide derived ... JAB1 (Jun activation domain-binding protein ... for the JAB1 protein. ... Jurkat cell lysates). Applications: ...

...

Biology Products:

GIBCO Calf Serum; Heat-Inactivated from Invitrogen MagicMark XP Western Protein Standard from Invitrogen Mouse Anti-JAB1 (Mid) Monoclonal Antibody, Clone 3F10B10 from Invitrogen Sheep Serum from CHEMICON